SAN DIEGO, March 26, 2018 -- Heroin Detox Clinics completes new informational page about heroin drug rehabs and substance abuse in Providence RI. The new article explains that simple detox has about a 90 percent failure rate. Opioid addicted inmates go through involuntary detox once they are incarcerated. But they are not given any tools for complete rehabilitation for when they get out. Opioid users build up a tolerance for the quantity needed for the same high. Upon release, they go right back to the amount they used upon going into jail which results in a very high rate of overdose deaths. Their bodies can no longer tolerate the higher dosage.
|
|||||
According to the Substance Abuse and Mental Health Services Administration (SAMSHA), successful sobriety has been aided by using FDA-approved medications along with proven therapies allowing the user to remain in recovery and treatment long enough to get the help they need. Providence began their program in 2016 finding opioid addicted inmates and using the MAT procedure which resulted in a 61 percent decrease in post incarceration overdose deaths. Could this become the model for the nation in reducing opioid related overdose deaths? Dr. Josiah “Jody” Rich, professor of medicine and epidemiology at Brown University and director of the Center for Prisoner Health and Human Rights at The Miriam Hospital in Providence believes that this program can definitely reduce the mortality rate of opioid deaths. Heroin rehabs in Providence offer help for struggling addicts to recover from opiate addiction.
Three different types of drug therapies were used by the Rhode Island Department of Corrections (RIDOC). Naltrexone is a drug that blocks people from experiencing the feeling of getting high therefore reducing their desire for the opioids but this drug can only be taken once the person has detoxed and should be used as a part of a complete treatment program that includes monitoring, counseling, behavioral contract and lifestyle changes. The two other drugs used are methadone and buprenorphine which are opioid medications that help reduce the withdrawal symptoms. Each patient is evaluated and given the treatment that fits them as an individual.
Two more very important parts of this program was using CODAC Behavioral Health, a nonprofit provider of medications for addiction treatment, that provide and administer MAT inside the correction facilities. Once the inmate is released, they are able to continue their treatment without interruption. Primary care providers, Centers of Excellence in MAT as well as CODAC will continue to treat the individual. Re-enrolling in a health insurance plan that will cover treatment is also supported to ensure they will stay in the program and remain on the sobriety path to becoming a productive part of the community.
Author: William Leonard
Organization: HeroinDetoxClinics.com
Address: 27420 Jefferson Ave, Temecula, CA 92590
Phone: 888-325-2454
http://heroindetoxclinics.com/
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/70b3c620-4e8f-486a-8a4b-f1e05c4dc83c


DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Apple Restores Telegram to App Store After Content Policy Violation
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Jetstar to Charge for Overhead Cabin Bags From February
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 



